Cost-of-illness of patients with systemic sclerosis in a tertiary care centre.

Objective: The aim of our study was to assess the costs of SSc and to analyse cost drivers.

Methods: A cross-sectional survey of consecutive patients with SSc was performed in a rheumatology centre in Hungary. Clinical characteristics, the European Scleroderma Study Group activity index, disease severity scale (DSS), scleroderma HAQ (S-HAQ) and health care utilization were recorded.